We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLCM
2601
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$15K ﹤0.01%
202
-974
-83% -$75.9K
NSEC
2602
DELISTED
National Security Group Inc
NSEC
$15K ﹤0.01%
+902
New +$14.4K
SUNS
2603
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$15K ﹤0.01%
891
+741
+494% +$12.5K
DLPH
2604
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$15K ﹤0.01%
328
-5,382
-94% -$269K
MINI
2605
DELISTED
Mobile Mini Inc
MINI
$15K ﹤0.01%
+319
New +$14.4K
WEBK
2606
DELISTED
Wellesley Bancorp, Inc.
WEBK
$15K ﹤0.01%
+474
New +$15.4K
MFSF
2607
DELISTED
MutualFirst Financial Inc
MFSF
$15K ﹤0.01%
+398
New +$14.9K
PIR
2608
DELISTED
Pier 1 Imports, Inc.
PIR
$15K ﹤0.01%
+306
New +$16.5K
PSDO
2609
DELISTED
Presidio, Inc. Common Stock
PSDO
$15K ﹤0.01%
+1,154
New +$16.8K
ANFI
2610
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$15K ﹤0.01%
6,886
+6,401
+1,320% +$19.5K
EMKR
2611
DELISTED
Emcore Corp
EMKR
$15K ﹤0.01%
306
-2
-0.6% -$101
IMH
2612
DELISTED
Impac Mortgage Holdings Inc.
IMH
$15K ﹤0.01%
+1,523
New +$13.6K
ALEX
2613
DELISTED
Alexander & Baldwin
ALEX
$14K ﹤0.01%
581
-11,099
-95% -$247K
AM icon
2614
Antero Midstream
AM
$10.1B
$14K ﹤0.01%
732
-6,952
-90% -$123K
APVO icon
2615
Aptevo Therapeutics
APVO
$5.21M
0
DAIO icon
2616
Data I/O
DAIO
$30.6M
$14K ﹤0.01%
2,162
-257
-11% -$1.82K
DSGR icon
2617
Distribution Solutions Group
DSGR
$1.61B
$14K ﹤0.01%
1,174
-7,552
-87% -$91.2K
EVRI
2618
DELISTED
Everi Holdings
EVRI
$14K ﹤0.01%
2,004
+257
+15% +$1.84K
EXEL icon
2619
Exelixis
EXEL
$13.4B
$14K ﹤0.01%
665
-8,077
-92% -$167K
GLRE icon
2620
Greenlight Captial
GLRE
$506M
$14K ﹤0.01%
951
-133
-12% -$2.02K
HLNE icon
2621
Hamilton Lane
HLNE
$5.57B
$14K ﹤0.01%
283
-3,910
-93% -$172K
JRSH icon
2622
Jerash Holdings
JRSH
$63.5M
$14K ﹤0.01%
+1,858
New +$15.8K
MBB icon
2623
iShares MBS ETF
MBB
$39.1B
$14K ﹤0.01%
+135
New +$14K
OFS icon
2624
OFS Capital
OFS
$51.9M
$14K ﹤0.01%
1,241
-273
-18% -$3.05K
OSBC icon
2625
Old Second Bancorp
OSBC
$1.29B
$14K ﹤0.01%
+981
New +$14.3K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.